Lilly’s three-pronged obesity drug hits goal in large diabetes trial
Lilly’s three-pronged obesity drug hits goal in large diabetes trial
Body unavailable. Use the original source.
Lilly’s three-pronged obesity drug hits goal in large diabetes trial
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.